Medicare Enrolled

Dr. James Melville, D.D.S

Oral and Maxillofacial Surgery (Dentist) · Houston, TX
Speaking/Promotional
6550 FANNIN ST, Houston, TX 77030
7137904600
In practice since 2008 (17 years)
NPI: 1972751907 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melville from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melville? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melville

Dr. James Melville is an oral and maxillofacial surgery specialist in Houston, TX, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Melville received a total of $168,202 from 18 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in oral and maxillofacial surgery (dentist). The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melville is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $168,202 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$168,202
Total received (2018-2024)
Avg $24,029/year across 7 years
Top 0% in TX for oral and maxillofacial surgery (dentist)
18
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131,609 (78.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$26,175 (15.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,419 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$59,057
2023
$30,844
2022
$14,877
2021
$6,625
2020
$23,706
2019
$30,505
2018
$2,588

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AXOGEN
$126,386
Kerecis Limited
$28,073
KLS-Martin L.P.
$5,976
Medical Device Business Services, Inc.
$3,059
ACELL, INC.
$2,175
Stryker Corporation
$642
DePuy Synthes Sales Inc.
$328
Integra LifeSciences Corporation
$305
Zimmer Biomet Holdings, Inc.
$301
Becton, Dickinson and Company
$261
BioTissue Holdings, Inc.
$223
Checkpoint Surgical, Inc
$164
LifeNet Health
$105
Nobel Biocare USA
$72
Acera Surgical, Inc.
$70
Davol Inc.
$24
3D Systems
$23
Ethicon US, LLC
$14
Top 3 companies account for 95.4% of total payments
Associated products mentioned in payments ›
ARISTA AH FlexiTip · AVANCE NERVE GRAFT · AXSOS · Avance Nerve Graft · AxoGuard Nerve Connector · AxoGuard Nerve Protector · CUSTOMIZED MANDIBLE RECON · CYTAL · Checkpoint Stimulators · DELTA SYSTEM 1.72.2 · ETHICON · Integra · Kerecis Omega3 SurgiClose · MATRIXMANDIBLE · NA · NEOX · NEUROMEND · NOBELACTIVE · PROKERA · Restrata Wound Matrix · TRUMATCH · Triple Bundle · VSP CRANIAL · VSP SYSTEM · ViviGen · Walter
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in oral and maxillofacial surgery (dentist) and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for oral and maxillofacial surgery (dentist) in TX.

Looking for an oral and maxillofacial surgery specialist in Houston?
Compare oral and maxillofacial surgerists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse oral and maxillofacial surgerists nearby

Geographic Context

Oral and maxillofacial surgerists within 10 mi
95
Per 100K population
2.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Melville is an oral and maxillofacial surgery specialist, with speaking/promotional industry engagement in the top 0% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Melville receive payments from pharmaceutical companies?
Yes. Dr. Melville received a total of $168,202 from 18 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Melville) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →